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1. Introduction 
Aortic stenosis (AS) is the most prevalent valvular heart disease in developed countries1). 
Aortic valves deteriorate due to degenerative processes, and calcification is the most 
frequent cause of AS. Clinical factors related to aortic valve calcification are similar to those 
for atherosclerosis, and the prevalence of calcified aortic valves increases with age2). As a 
consequence, AS is associated with a high risk of cardiovascular morbidity and mortality in 
the elderly3). To achieve longer life expectancy, aortic valve replacement (AVR) is 
recommended as a definitive treatment for calcified aortic valves4,5). Although the operative 
mortality of isolated AVR is low, the surgical risk is increased in elderly patients due to 
concomitant procedures and/or comorbidities associated with advanced age6). Thus, it is 
very important to plan a careful strategy for co-existing atherosclerotic lesions, especially in 
the ascending aorta. 
Atherosclerotic change in the ascending aorta is one of the potential causes of postoperative 
stroke, which results in higher morbidity and mortality7,8). Most embolic events are 
associated with manipulation of the ascending aorta such as the clamping of the ascending 
aorta or the release of aortic crossclamping9). To reduce embolic complications, surgical 
treatments have changed, and there are several techniques, including AVR during 
hypothermic circulatory arrest (HCA)10-12), complete thromboendarterectomy during 
HCA13), endarterectomy or ascending aorta replacement during HCA14), endoaortic balloon 
occlusion15), and apicoaortic conduit16). Despite aggressive attempts to deal with the calcified 
ascending aorta, surgical outcomes such as the stroke rate, morbidity, and mortality have 
remained unsatisfactory. This paper describes our surgical strategy for patients with AS 
associated with a diseased calcified ascending aorta. Furthermore, meticulous techniques for 
atherosclerotic lesions designed to avoid perioperative morbidity are described in detail. 
2. Patients and methods 
2.1 Patients 
Between May 2000 and December 2009, 705 patients underwent AVR due to AS (n=447) or 
aortic regurgitation (n=268). Of the patients with AS, 46 (11%) had a calcified ascending 
aorta. A calcified ascending aorta is defined on computed tomography (CT) as severe and 
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extensive calcification, which would increase the risk of atheroembolic complications during 
operative procedures. 
The patients were 25 males and 21 females, ranging between 44 and 93 years of age (mean, 
73±10 years). Hemodialysis was required in 6 patients (13%) due to chronic renal failure. In 
this series, 10 patients (22%) had a porcelain aorta (a totally calcified aorta). Although 
preoperative imaging obtained by CT revealed the extent and thickness of calcification of 
the ascending aorta, operative procedures were determined by intra-operative findings. 
2.2 Surgical technique 
2.2.1 Preparation 
Under general cardiac anesthesia and monitoring, an 8-mm, gelatin-impregnated, woven 
Dacron graft (Gelweave; VASCUTEK®, a TERUMO company, Renfrewshire, UK) was sewn 
to the right axillary artery17). After median sternotomy, cardiopulmonary bypass (CPB) was 
installed via the right axillary artery with single venous drainage. A pulmonary vein vent 
was used to prevent potentially damaging distension during ventricular fibrillation. The 
body was cooled to 28°C for internal inspection of the ascending aorta during brief 
circulatory arrest. Gentle palpation of the ascending aorta provided three-dimensional 
spatial imaging of the calcified aorta during cooling. Epiaortic echocardiography was also 
used to obtain intimal imaging of the ascending aorta along aortotomy. 
2.2.2 Brief circulatory arrest for internal inspection of the ascending aorta 
At a core body temperature of 28°C, brief circulatory arrest was initiated to observe the 
intimal condition of the ascending aorta. The ascending aorta was opened at the optimal 
site, which was determined by gentle palpation and epiaortic echocardiography. An oblique 
(J-shaped) incision is usually used for AVR. When severe calcification involves the sinus of 
Valsalva, a longitudinal (I-shaped) incision or transection would be indicated (Fig. 1); a 
representative CT image of a calcified sinus of Valsalva is shown in Fig. 2. A severely 
calcified sinus of Valsalva prevents surgeons from obtaining a satisfactory surgical field 
around the aortic annulus, even if the anterior wall of the ascending aorta is retracted 
through the usual oblique incision. Moreover, prosthetic valves cannot be passed through a 
calcified sinus of Valsalva due to the limited diameter caused by nearly-circumferential 
calcification and the height of the prosthesis. For these reasons, it is very important to 
extend the I-shaped aortic incision to the sinus of Valsalva toward the commissure between 
the right and non-coronary cusps. After opening the ascending aorta, the intima was 
directly observed to confirm the existence of fragile debris. When the calcified ascending 
aorta was clampable at a safe site with just only calcification but no fragile debris, simple 
AVR was indicated. When there was severe calcification and no lesion for aortic 
crossclamping, both AVR and ascending aorta replacement were indicated during 
circulatory arrest with selective cerebral perfusion. 
2.2.3 Simple AVR 
The calcified ascending aorta was safely crossclamped after internal inspection of the 
ascending aorta during brief circulatory arrest at moderate hypothermia. Systemic perfusion 
was commenced via the right axillary artery after aortic crossclamping. Re-warming of the 
body was then started. Antegrade tepid blood cardioplegia was selectively delivered to 
obtain diastolic cardiac arrest. For maintenance, retrograde tepid blood cardioplegia was 
infused every 20 to 30 minutes. When remnant fragile debris was detected on the proximal 
ascending aorta, it was gently peeled as far as possible before AVR. 
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Fig. 1. A schema of the incisions of the ascending aorta for aortic valve replacement (AVR). 
There are three incision lines for aortotomy on the ascending aorta. The oblique (J-shaped) 
line for routine AVR is shown by the solid arrow. The horizontal or longitudinal (I-shaped) 
and transverse lines for patients with a calcified sinus of Valsalva are shown by dotted 
arrows. (Hirota et al.) 
 
 
Fig. 2. On the left side, calcification of the aorta is shown by three-dimensional computed 
tomography (CT) images in a patient with a calcified sinus of Valsalva. On the right side, a 
representative image of a calcified sinus of Valsalva is obtained from the scanning level 
shown by a solid line on the three-dimensional CT. Nearly-circumferential calcification is 
detected on the sinus of Valsalva. (Hirota et al.) 
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Firstly, the aortic valves were sharply removed, and one-quarter of gauze was placed into 
the left ventricle (LV) to catch calcific debris. Decalcification was gently performed with 
Pean Hemostatic Forceps and Selman Tissue Forceps (Pilling®; Teleflex Medical, Tuttlingen, 
Germany) around the aortic annulus. The LV cavity was carefully irrigated with copious 
amounts of cold saline to reduce the risk of emboli. Secondly, a 2-0 polyfilament braided 
non-everting mattress suture with spaghetti (Matsuda-ika Kogyo, Tokyo, Japan) was placed 
for each commissure. Great attention is needed for commissural suturing between the right 
and non-coronary cusps. Deep stitches for the commissure would injure the conduction 
system, which would result in complete atrioventricular block. For patients with this 
complication, permanent pacemaker implantation would be necessary. Subsequently, sizing 
of the prosthetic valve was performed in accordance with each commercial sizer. When a 
bioprosthetic valve was selected, it was irrigated with saline for preparation. Thirdly, inter-
commissural sutures were placed for each coronary cusp. Independent of the type of 
prosthetic valve, 15 sutures, one for each commissure and four for each coronary cusp, were 
usually placed (Fig. 3). Then, a total of 15 sutures was placed on the prosthetic annulus, and 
the appropriate valve was seated in the supravalvular position. 
 
 
Fig. 3. Independent of the type of prosthetic valve, 15 2-0 polyfilament braided non-everting 
mattress sutures with spaghetti were usually placed for routine aortic valve replacement. 
Firstly, three black sutures were placed for each commissure. Secondly, four sutures, 
alternating white and blue, were placed for each coronary cusp. (Hirota et al.) 
2.2.4 Closure of a calcified ascending aorta 
For patients with a non-calcified aortic wall, the ascending aorta is usually closed with 5-0 
polypropylene continuous horizontal mattress and over-and-over sutures. However, for 
patients with a fragile aortic wall, the aortotomy was closed with 4-0 polyfilament braided  
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Fig. 4. 4A. For patients with a fragile aortic wall, the aortotomy was closed with 4-0 
polyfilament braided horizontal mattress and 5-0 polypropylene over-and-over sutures.  4B. 
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For patients with a severely calcified aorta, a knitted polyester strip of 2 cm in width was 
placed over the aortotomy. It was fixed with 4-0 polyfilament braided horizontal mattress 
sutures. Except for the two central sutures, all sutures were tied down.  4C. Closure of the 
aortotomy was started with 5-0 polypropylene over-and-over sutures from both edges 
toward the central untied sutures.  4D. The aortotomy for the two untied sutures (about 2 
cm in length) was kept open. Under low-flow cardiopulmonary bypass, the ascending aorta 
was carefully declamped to flush out remaining debris from the aortotomy for about 30 
seconds. (Hirota et al.) 
horizontal mattress (Matsuda-ika Kogyo, Tokyo, Japan) and 5-0 polypropylene over-and-
over sutures (Prolene®; Ethicon, Somerville, NJ, USA) (Fig. 4A). When the edges of the 
aortotomy included calcification, an endarterectomy was performed to facilitate closure of 
the ascending aorta. 
For patients with a severely calcified aorta, a knitted polyester strip of 2 cm in width (Sauvage 
Filamentous Fabric®; Bard Peripheral Vascular Inc., Tempe, AZ, USA) was used to prevent 
cutting and injury of the calcified ascending aorta. The left end of the strip was divided to 
place over the aortotomy. At first, 4-0 polyfilament braided horizontal mattress sutures were 
required for both ends to fix the trimmed strip. Other horizontal mattress sutures were placed 
along the aortotomy. Except for the two central sutures, all sutures were tied down (Fig. 4B). 
Then, aortotomy closure was started with 5-0 polypropylene over-and-over sutures from both 
edges toward the central untied sutures (Fig. 4C). The aortotomy between the two untied 
sutures (about 2 cm in length) was kept open to flush out the debris. Under low CPB flow, the 
ascending aorta was carefully declamped with manual occlusion of the neck vessels. A 
sufficient amount of blood was flushed out from the aortotomy for about 30 seconds (Fig. 4D). 
Then, the two central sutures were tied down. The central portion of the aortotomy was 
reinforced with 5-0 polypropylene over-and-over suture. 
2.2.5 AVR plus ascending aorta replacement 
When simple AVR cannot be safely performed due to an unclampable ascending aorta, AVR 
plus ascending aorta replacement is selected for these patients. During circulatory arrest at a 
core body temperature of 28°C, cerebral perfusion was selectively initiated. Antegrade tepid 
blood cardioplegia was selectively delivered to obtain cardioplegic cardiac arrest. For 
maintenance, retrograde tepid blood cardioplegia was infused every 20 to 30 minutes. 
The ascending aorta was transected above the level of the sinotubular junction and 
subsequently transected below the level of the innominate artery. The prosthetic aortic valve 
was seated in the supravalvular position. The technical details of the AVR were described 
above. After seating the prosthetic valve, localized endarterectomy for the distal anastomosis 
was performed if needed. The distal end of the ascending aorta was encircled by a 2-cm-wide 
felt strip. A gelatin-impregnated, woven Dacron graft (J Graft SEALED NEO®; JUNKEN-
MEDICAL Co., Japan Lifeline, Saitama, Japan) with one side branch was implanted as open 
distal anastomosis. It was sewn to the distal end of the ascending aorta with 4-0 polyfilament 
braided sutures in a horizontal mattress fashion (Fig. 5A). The distal end of the Dacron graft (1 
cm in length) was gently fixed in an inverted form (Fig. 5B). Then, the anastomosis was 
reinforced with additional 3-0 polypropylene over-and-over suture (Fig. 5C). After completion 
of the distal anastomosis, cerebral perfusion was withdrawn, and antegrade systemic 
perfusion was started via the side branch of the Dacron graft (Fig. 5D). 
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Fig. 5. 5A. A Dacron graft with one side branch was sewn to the distal end of the ascending 
aorta with 4-0 polyfilament braided sutures in a horizontal mattress fashion.  5B. The distal 
end of the Dacron graft (1 cm in length) was gently fixed in an inverted form.  5C. The 
anastomosis was reinforced with additional 3-0 polypropylene over-and-over suture.  5D. 
After completion of the distal anastomosis, cerebral perfusion was withdrawn, and antegrade 
systemic perfusion was started via the side branch of the Dacron graft. (Hirota et al.) 
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The proximal anastomosis was completed by single 3-0 polypropylene running sutures. 
Firstly, the proximal end of the graft was sewn to the posterior wall of the proximal aorta 
with 3-0 polypropylene running suture. Then, both ends of the suture were tied with other 
3-0 polypropylene sutures to avoid relaxation of the posterior anastomosis. Thus, the 
posterior wall of the graft was fixed in an inverted form (Fig. 6A). Secondly, one stay suture 
was placed at the toe for easy adjustment (Fig. 6B). Thirdly, the anterior wall of the graft 
was sewn to the proximal aorta with 3-0 polypropylene running sutures from both ends 
(Fig. 6C). 
2.2.6 Concomitant procedure 
In combined coronary artery bypass grafting (CABG) and AVR procedures, distal 
anastomoses were completed without crossclamping during cooling. For beating CABG 
procedures, a heart retracting system with the Tentacles Heart Positioner (Sumitomo Bakelite, 
Tokyo, Japan), which provides excellent exposure of target coronary arteries18), is usually used. 
Proximal anastomoses were performed during single crossclamping after AVR. 
In combined mitral valve surgery and AVR, mitral valve plasty (MVP) or mitral valve 
replacement (MVR) was performed prior to AVR. For patients not requiring ascending aorta 
replacement, the ascending aorta was crossclamped after brief circulatory arrest. 
Subsequently, mitral valve surgery was initiated prior to AVR. For patients with ascending 
aorta replacement, the distal end of the ascending aorta was firstly sewn to a Dacron graft 
with one side branch during circulatory arrest (Fig. 6A). After the distal anastomosis, 
systemic and cerebral perfusion was antegradely maintained via the side branch of the graft 
(Fig. 6B). Then, mitral valve surgery was initiated prior to AVR. When the left side Maze 
procedure was indicated, it was performed via the right-sided left atriotomy during mitral 
valve surgery. After completion of mitral valve surgery, AVR was started as described 
above. Subsequently, the left atrium was closed and the proximal anastomosis of the 
ascending aorta was performed (Fig. 6C). Finally, the right side Maze procedure and/or 
tricuspid valve surgery was performed through the right atriotomy. 
3. Results 
Of a total of 705 patients having AVR, 46 patients (11%) with a calcified ascending aorta 
required brief circulatory arrest for internal inspection of the ascending aorta. Of these 46 
patients, 42 (92%) underwent simple AVR after safe aortic crossclamping. The duration of 
circulatory arrest was less than 1 min in 40 patients and the longest duration was 3 min (mean 
0.9±0.6 min). In 3 patients (7%), AVR plus ascending aorta replacement was performed due to 
an unclampable ascending aorta during circulatory arrest at moderate hypothermia (28°C). For 
1 patient (1%), the Bentall operation was done due to a dilated sinus of Valsalva. 
In this series, patients had AVR with a bioprosthetic (n=31; 67%) or a mechanical valve 
(n=15; 33%). Twenty-two patients (48%) had Carpentier-Edwards pericardial valves 
(Edwards Life Science Corporation, Irvine, CA, USA), 9 patients (20%) had CarboMedics 
Top Hat mechanical valves (CarboMedics, Inc., Austin, TX, USA), 6 patients (13%) had Sorin 
Bicarbon-Slim mechanical valves (Sorin Biomedica, Saluggia, Italy), 5 patients (11%) had 
Medtronic Mosaic valves (Medtronic Inc., Minneapolis, MN, USA), 1 patient had a Prima 
Plus Stentless valve (Edwards Life Science Corporation), and 1 patient had a Medtronic 
Freestyle valve (Medtronic Inc.). 
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Fig. 6. 6A. The proximal end of the graft was sewn to the posterior wall of the proximal 
aorta with 3-0 polypropylene running suture.  6B. Both ends of the suture were tied with 
other 3-0 polypropylene sutures to avoid relaxation of the posterior anastomosis. Thus, the 
posterior wall of the graft was fixed in an inverted form. One stay suture was placed at the 
toe for easy adjustment.  6C. The anterior wall of the graft was sewn to the proximal aorta 
with 3-0 polypropylene running sutures from both ends. (Hirota et al.) 
Twenty-seven patients (59%) had concomitant procedures including CABG (n=18), MVR 
(n=6), MVP (n=2), the Maze procedure (n=4), and tricuspid annuloplasty (n=3). No intra-
aortic balloon pumping was required postoperatively. Aortic crossclamping time was 76±18 
min. CPB time was 148±29 min. Operative time was 330±69 min. The hospital mortality was 
2.2% (1 of 46). One patient died of gastrointestinal bleeding. There was no cardiogenic death 
in this series. The postoperative morbidity was 2.2% (1 of 46). Cerebrovascular accident 
occurred in one patient. 
4. Discussion 
Patients with AS and a calcified ascending aorta were treated with meticulous techniques. 
Careful maneuvers for calcified lesions would reduce atheroembolic complications, 
contributing to better surgical outcomes. 
The surgical challenge of dealing with patients with AS and calcified ascending aorta started 
in the 1980s10,11). With advances in medical technology, the surgical strategy has been 
modified in various ways. Theoretically, the simplest approach is supposed to be AVR 
without aortic crossclamping during HCA10-12). Although the no-touch technique to the 
calcified aorta effectively reduces the surgical risk of atheroembolic events, prolonged HCA 
time is a risk for stroke19). As a different strategy to facilitate AVR, endarterectomy during 
HCA has been reported to avoid embolic events13,20). No patients with postoperative stroke 
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suggested a good early result, but there were no follow-up data relating to the long-term 
risks of aortic dissection or dilatation. Although HCA provides simple strategies for patients 
with AS and a calcified ascending aorta, technical modifications are needed to render the 
procedure less invasive. 
Aortic crossclamping is one of the most technically difficult aspects for patients with a 
calcified ascending aorta. The release of aortic crossclamping is closely associated with 
embolic events during cardiac surgery9). As an alternative for aortic crossclamping, a 
method of internal occlusion of the ascending aorta was reported; i.e., endoaortic balloon 
occlusion15). According to that report, a Foley catheter was directly introduced via the usual 
aortotomy during a brief period of circulatory arrest at a nasopharyngeal temperature of 
25°C. Although the advantages of endoaortic balloon occlusion include easy preparation 
and less invasive technique, a retrospective analysis demonstrated that it was frequently 
ineffective and was associated with a significantly higher risk of in-hospital death and a 
numerically higher risk of stroke21). 
We used brief circulatory arrest less than 1 min in most cases at moderate hypothermia 
(28°C) for internal inspection of calcified ascending aorta. The extent and severity of 
calcification is directly observed, and the firmness of the calcified ascending aorta is also 
palpable without wall stress caused by afterload. Thus, in this situation, it is easy to 
determine whether the calcified ascending aorta is clampable. When the calcified ascending 
aorta is clampable, simple AVR followed by aortic crossclamping is planned as a less 
invasive operation. However, ascending aorta replacement would be performed for patients 
with an unclampable calcified ascending aorta. At moderate hypothermia (28°C), simple 
AVR could be converted into ascending aorta replacement under circulatory arrest with 
selective cerebral perfusion. Thus, patients with AS and calcified ascending aorta are 
surgically repaired by our strategy without deep HCA. 
A recent surgical report also demonstrated that short-term moderate hypothermic arrest is 
useful for safe aortic crossclamping after internal inspection of a bad ascending aorta22). 
Although this technique for safe crossclamping is almost the same as our strategy, all cases 
were treated with simple AVR followed by aortic crossclamping. The reason for this would 
include endarterectomy or debridement by the Cavitron ultrasonic surgical aspirator 
(CUSA)23), which successfully achieves a safe aortic crossclamping site. Therefore, 
circulatory arrest time was slightly longer (3.4±1.5 min) compared to ours (less than 1 min). 
Although small calcific particles created by the CUSA are potential causes of postoperative 
stroke, all of them would be completely aspirated. As a result, the postoperative stroke rate 
remained low (2.5%), with no mortality. For patients with a calcified ascending aorta, the 
CUSA would also be useful for removing calcific debris during AVR. 
As one of the alternatives for open heart surgery, transcatheter valve implantation (TAVI) 
had been newly developed for symptomatic patients at high risk or with contraindications 
for surgery24). A calcified ascending aorta would be a good indication for TAVI. Successful 
TAVI dramatically alleviates severe symptoms with a minimally-invasive method. 
However, TAVI involves major complications such as paravalvular leakage, valve 
malposition, coronary occlusion, annulus and aortic root rupture, atrioventricular block, and 
cerebrovascular events25). The 30-day all-cause mortality rate with the CoreValve Revalving 
System (Medtronic Inc.) ranges from 5.5% to 15.5%, while that with the Edwards Sapien 
prosthesis (Edwards Life Science Corporation) ranges from 6.3% to 10.3%25). Although the 
incidence of persistent neurological impairment was low (less than approximately 5%), the 
incidence of clinically silent peri-interventricular cerebral embolic lesions after TAVI was 
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high25,26). The results of TAVI would be improved by further development of medical 
devices, but current results are not far superior to our surgical outcomes. Accordingly, there 
is no established treatment for AS and calcified ascending aorta at present. 
In the future, prevalence of calcified lesions, including AS and calcified ascending aorta, is 
likely to increase as the average lifespan of populations increases. With the advances in 
medical technologies, new therapeutic technologies, such as TAVI, will be developed for 
safer strategies and to minimize invasiveness. However, TAVI is not the optimal treatment 
for all patients with AS, including patients requiring concomitant procedures such as CABG 
and mitral valve surgery. For these patients, conventional open heart surgery would be one 
of the therapeutic choices. Additionally, state-of-the-art technologies will not be available 
worldwide. Thus, cardiac surgeons should continue to modify their strategies by meticulous 
techniques and share their strategies for better outcomes. Addressing this surgical challenge 
would result in resolution for many more high-risk patients with complex calcified lesions.  
5. Conclusion 
Technical modifications such as right axillary artery cannulation and brief circulatory arrest 
at moderate hypothermia are useful for patients with AS associated with a calcified 
ascending aorta. The operative design would be important to minimize the surgical risk for 
such high-risk patients. 
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